Mouridsen Ht

756 total citations
34 papers, 615 citations indexed

About

Mouridsen Ht is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Mouridsen Ht has authored 34 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Cancer Research and 9 papers in Genetics. Recurrent topics in Mouridsen Ht's work include Cancer Treatment and Pharmacology (13 papers), Breast Cancer Treatment Studies (11 papers) and Estrogen and related hormone effects (6 papers). Mouridsen Ht is often cited by papers focused on Cancer Treatment and Pharmacology (13 papers), Breast Cancer Treatment Studies (11 papers) and Estrogen and related hormone effects (6 papers). Mouridsen Ht collaborates with scholars based in Denmark, Italy and United States. Mouridsen Ht's co-authors include K Fischerman, Marianne Ewertz, H Brincker, Torben Palshof, P Dombernowsky, Niels Nygaard Rossing, Niels Keiding, Mikael Rørth, W. Mattsson and K Hou-Jensen and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Mouridsen Ht

32 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mouridsen Ht Denmark	14	366	294	193	95	85	34	615
Å Rimsten Sweden	14	352 1.0×	201 0.7×	163 0.8×	164 1.7×	36 0.4×	34	609
J. Carpenter United States	9	390 1.1×	296 1.0×	230 1.2×	92 1.0×	135 1.6×	23	720
Charles D. Cobau United States	8	276 0.8×	199 0.7×	70 0.4×	81 0.9×	105 1.2×	18	556
Liesbeth Bergman Netherlands	7	311 0.8×	239 0.8×	302 1.6×	79 0.8×	94 1.1×	10	802
T Palva Finland	8	426 1.2×	179 0.6×	277 1.4×	120 1.3×	145 1.7×	13	663
John L. Hayward United Kingdom	15	383 1.0×	310 1.1×	132 0.7×	165 1.7×	207 2.4×	20	733
HelenJ. Stewart United Kingdom	9	231 0.6×	334 1.1×	323 1.7×	183 1.9×	49 0.6×	19	777
H. B. Muss United States	13	380 1.0×	200 0.7×	193 1.0×	35 0.4×	99 1.2×	28	636
J Robert Canada	9	586 1.6×	445 1.5×	105 0.5×	120 1.3×	194 2.3×	16	955
G Martz Switzerland	14	336 0.9×	134 0.5×	122 0.6×	48 0.5×	122 1.4×	36	535

Countries citing papers authored by Mouridsen Ht

Since Specialization

Citations

This map shows the geographic impact of Mouridsen Ht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mouridsen Ht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mouridsen Ht more than expected).

Fields of papers citing papers by Mouridsen Ht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mouridsen Ht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mouridsen Ht. The network helps show where Mouridsen Ht may publish in the future.

Co-authorship network of co-authors of Mouridsen Ht

This figure shows the co-authorship network connecting the top 25 collaborators of Mouridsen Ht. A scholar is included among the top collaborators of Mouridsen Ht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mouridsen Ht. Mouridsen Ht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jørgensen, Torben, et al.. (1996). [Mammographic screening in the municipality of Copenhagen. Results of the first screening round].. PubMed. 158(9). 1212–7. 4 indexed citations

Andreasen, Anne Helms, et al.. (1994). [Improved prognosis of breast cancer].. PubMed. 156(44). 6512–7. 5 indexed citations

Kroman, Niels, et al.. (1994). Timing of surgery in relation to menstrual cycle does not predict the prognosis in primary breast cancer. Danish Breast Cancer Cooperative Group.. PubMed. 20(4). 430–5. 28 indexed citations

Ht, Mouridsen, et al.. (1992). Classical prognostic factors in node-negative breast cancer: the DBCG experience.. PubMed. 163–6. 13 indexed citations

Ck, Axelsson, et al.. (1991). [Rationalization profits of radiographic diagnosis with systematic follow-up DBCG (Danish Breast Cancer Cooperative Group) programs. 1].. PubMed. 153(33). 2270–2. 1 indexed citations

Ck, Axelsson, M Blichert-Toft, P Dombernowsky, et al.. (1991). [Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group)].. PubMed. 153(33). 2276–9. 1 indexed citations

Ht, Mouridsen, P Dombernowsky, Jensen Om, et al.. (1990). [Sarcoma treatment in Denmark].. PubMed. 152(14). 989–92. 3 indexed citations

Ernst, P, I. Balslev, & Mouridsen Ht. (1987). Second-line chemotherapy with tauromustine in metastatic breast cancer in postmenopausal women: a phase II study.. PubMed. 71(10). 987–8. 1 indexed citations

Ht, Mouridsen, et al.. (1986). Steroid hormone receptors as prognostic indicators in primary breast cancer.. PubMed. 7 Suppl. S91–7. 29 indexed citations

10.

Ht, Mouridsen, et al.. (1986). Adjuvant tamoxifen in postmenopausal high-risk breast cancer patients: present status of Danish Breast Cancer Cooperative Group trials.. PubMed. 115–8. 22 indexed citations

11.

Ht, Mouridsen. (1986). Prednimustine in advanced breast cancer: a review.. PubMed. 13(1 Suppl 1). 27–31. 4 indexed citations

12.

Fischerman, K & Mouridsen Ht. (1984). Danish Breast Cancer Cooperative Group (DBCG). Present status and experience.. PubMed. 519. 55–9. 8 indexed citations

13.

Ht, Mouridsen, et al.. (1982). Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.. PubMed. 66(12). 2081–3. 1 indexed citations

14.

Ht, Mouridsen, K Fischerman, Johan A. Andersen, et al.. (1981). Organisation of the Danish adjuvant trials in breast cancer.. PubMed. 28(3). 102–6. 77 indexed citations

15.

Ht, Mouridsen, et al.. (1980). Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.. PubMed. Suppl 1. 107–10. 12 indexed citations

16.

Ht, Mouridsen, et al.. (1979). Therapeutic effect of tamoxifen versus tamoxifen combined with medroxyprogesterone acetate in advanced breast cancer in postmenopausal women.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(2). 171–5. 38 indexed citations

17.

Fischerman, K & Mouridsen Ht. (1977). Danish Breast Cancer Cooperative Group--DBCG.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 139(42). 2493–4. 67 indexed citations

18.

Lauritzen, T., et al.. (1975). [Insulin Monotard and Insulin Lente. Comparison of absorption and clinical effects].. PubMed. 137(43). 2510–4. 5 indexed citations

19.

Ht, Mouridsen. (1968). The extravascular retention of serum albumin in the operative wound.. PubMed. 134(6). 417–21. 6 indexed citations

20.

Ht, Mouridsen. (1967). Turnover of human serum albumin before and after operations.. PubMed. 33(2). 345–54. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact